Top Markets
#1 DogBull DogBull +36.46%
#2 The Bitcoin Bull The Bitcoin Bull +31.37%
#3 Siacoin Siacoin +27.38%
#4 Merlin's Seal BTC Merlin's Seal BTC +25.80%
#5 Cash Cat Cash Cat +19.34%
#6 Ontology Gas Ontology Gas +18.55%
#7 MarsCoin MarsCoin +17.63%
#8 Pons Pons +17.48%
#9 Akedo Akedo +11.80%
#10 Uniswap Uniswap +11.35%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Foresee Pharmaceuticals Co., Ltd. Foresee Pharmaceuticals Co., Ltd.

Foresee Pharmaceuticals Co., Ltd.

6576
Rank in Stocks #14583
Foresee is a Taiwan and US-based biopharmaceutical company focused on two key... Foresee is a Taiwan and US-based biopharmaceutical company focused on two key areas: its unique Stabilized Injectable Formulation (SIF) long-acting injectable technology with derived drug products for specialty markets, and its transformative preclinical and clinical first-in-class New Chemical Entity (NCE) programs targeting rare and severe disease areas with high unmet needs. Its product portfolio includes late and early-stage programs, with its lead product CAMCEVI® used for the treatment of advanced prostate cancer.
Share Price
$2.58
Market Cap
$405.78M
Change (1 day)
-0.25%
Change (1 year)
1.54%
Country
TW
Trade Foresee Pharmaceuticals Co., Ltd. (6576)

Category

Healthcare
Revenue for Foresee Pharmaceuticals Co., Ltd. (6576)
Revenue in Sep 2026 TTM: 0
According to Foresee Pharmaceuticals Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Foresee Pharmaceuticals Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US